Tag Archives: Spinraza

Water Head Risk by Spinraza

[ad_1] In patients receiving nusinersen (Spinraza) for the treatment of SMA muscular disease (spinal muscular atrophy), symptoms of accumulation of cerebral fluid may develop. This is reported by the Medicines Evaluation Board …

Read More »